Amneal Pharmaceuticals

Amneal markets a portfolio of branded pharmaceutical products through its Specialty segment, with a primary focus on central nervous system and endocrine disorders.  Amneal’s Endocrinology sales force markets UNITHROID® (levothyroxine sodium tablets) in the U.S.

UNITHROID was the 1st FDA-Approved orally administered levothyroxine sodium treatment for hypothyroidism. UNITHROID tablets have been manufactured in the same facility in New York for more than 2 decades with no history of recalls, reformulations, or gaps in availability. In addition, with UNITHROID’s patient savings program, more than 90% of eligible commercially insured patients may pay as little as $3 for a 30-day prescription.

Do not use UNITHROID for the treatment of obesity or weight loss. Toxicity may occur if daily hormonal requirement is surpassed.  Please see Full Prescribing Information, including Boxed Warning at UnithroidHCP.com.